Ixico

(IXI)
Sector: Pharmaceuticals & Biotechnology
12.75p
0.00p 0.00
Last updated: 11:40:38

Director dealings

Trade date Director Volume / Price Trade value Trade type
28/10/2024 Kate Rogers 52,631 @ 9.50p £4,999.95 Placing
28/10/2024 Dipti Amin 105,263 @ 9.50p £9,999.99 Placing
28/10/2024 Grant Nash 105,263 @ 9.50p £9,999.99 Placing
10/10/2024 Mark Warne 26,370 @ 9.48p £2,499.88 Buy
09/10/2024 Mark Warne 26,315 @ 9.50p £2,499.93 Buy
09/10/2024 Grant Nash 200,000 @ 100.00p £200,000.00 Exercise of Option
22/12/2022 Grant Nash 200,000 @ 25.02p £50,040.00 Buy
22/12/2022 Grant Nash 200,000 @ 25.00p £50,000.00 Sell
12/12/2022 Grant Nash 200,000 @ 1.00p £2,000.00 Exercise of Option

Director shareholdings

Name Holding Percent
Grant Nash 505,263 0.00%
Giulio Cerroni 491,333 0.00%
Charles Spicer 333,196 0.00%
Dipti Amin 105,263 0.00%
Mark Warne 98,650 0.00%
Kate Rogers 52,631 0.00%

Major shareholders

Institution name Holding Percent
Octopus Investments 16,850,400 18.18%
Gresham House Asset Management 16,428,100 17.73%
BGF Investment Management Limited 12,887,000 13.91%
Canaccord Genuity Group Inc 7,471,000 8.06%
Amati AIM VCT plc 4,756,300 9.83%
CIP Merchant Capital Limited 3,857,566 7.98%